Insider trades

Kevin Balthaser, CFO of Aclaris Therapeutics ACRS, has filed 1 purchase and 2 sales on the open market. The latest trade was on 03/01.

Kevin Balthaser

CFO
First filing
23/02/03
Trades
74 trades
Buys / sales
1 / 2
12-month net buying
No record
Last trade
03/01

Trading activity

Transactions

Trade type
Open-market buy23/09/0623/09/079,490 sh$7.90$74,971+158.9%
ACRS
Open-market sale23/03/02–23/03/0323/03/031,894 sh2 trades$12.45avg.$23,581.22−26.5%